Andean highlanders adapt to thin air through epigenetic gene tuning, revealing a flexible, long-term path to altitude survival.

Celcuity has successfully transitioned from a speculative biotechnology company to a pre-commercial firm with a de-risked ...

An aggressive breast cancer lacking common drug targets, triple-negative breast cancer may be countered by oridonin, a ...

Early data suggest retatrutide may drive faster and greater weight loss, which fuels interest in looksmaxxing spaces.

THIS YEAR, the highly anticipated European Society for Medical Oncology (ESMO) Congress 2025 was held in Berlin, ...

Background Chronic stress is a known risk factor for cancer metastasis. However, the underlying mechanisms, particularly ...

MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its ...

Lung cancer remains the most frequently diagnosed malignancy and the leading cause of cancer tumour-related mortality ...